Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.3K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

71
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
71
Chemical Synapses01:26

Chemical Synapses

10.4K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.4K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The landscape of serum autoantibodies in lupus nephritis.

Autoimmunity reviews·2026
Same author

Inter-centre heterogeneity, temporal evolution, and factors associated with treatment selection and outcomes in chronic inflammatory demyelinating polyradiculoneuropathy: a multicentre, combined prospective and retrospective observational study.

EClinicalMedicine·2026
Same author

Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) guidelines on the use of autoantibody tests in the diagnosis of autoimmune liver diseases.

Autoimmunity reviews·2026
Same author

Validation of a Multiparametric, Automated, Macroarray-Based Assay for the Detection of Autoantibodies in Autoimmune Liver Disease.

Journal of clinical laboratory analysis·2026
Same author

Immune correlates underlying small fiber neuropathy presenting as vaccine-associated post-acute SARS- coronavirus syndrome.

Frontiers in immunology·2026
Same author

Autoantibody-mediated disorders of the central and peripheral nervous system.

Journal of neuroimmunology·2026

Related Experiment Video

Updated: Nov 6, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.6K

Improving laboratory diagnostics in myasthenia gravis.

Matteo Gastaldi1, Silvia Scaranzin1, Pietro Businaro2

  • 1Neuroimmunology Laboratory, IRCCS Mondino Foundation, Pavia, Italy.

Expert Review of Molecular Diagnostics
|May 10, 2021
PubMed
Summary

New cell-based assays (CBAs) offer alternatives to traditional radioimmunoprecipitation assays (RIPAs) for detecting myasthenia gravis (MG) autoantibodies. These methods may reduce seronegative cases and radioactive reagent use.

Keywords:
Autoantibodycell-based assayenzyme-linked immunosorbent assaylaboratory diagnosticslow molecular weight receptor related low-density lipoprotein 4muscle specific tyrosine kinasemyasthenia gravisneuroimmunologynicotinic acetylcholine receptorradioimmunoprecipitation assay

More Related Videos

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

9.2K
A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.9K

Related Experiment Videos

Last Updated: Nov 6, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.6K
Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

9.2K
A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.9K

Area of Science:

  • Neurology
  • Immunology
  • Clinical Chemistry

Background:

  • Myasthenia gravis (MG) is an autoimmune disorder affecting the neuromuscular junction.
  • Pathogenic autoantibodies target neuromuscular junction components.
  • Radioimmunoprecipitation assays (RIPAs) are the current gold standard for autoantibody detection.

Purpose of the Study:

  • To review advances in laboratory methods for MG autoantibody detection.
  • To highlight the role of cell-based assays (CBAs) in complementing or replacing RIPAs.
  • To discuss the diagnostic utility of novel assays for acetylcholine receptor (AChR), muscle-specific kinase (MuSK), and LRP4 antibodies.

Main Methods:

  • Discussion of emerging laboratory techniques, particularly cell-based assays (CBAs).
  • Comparison of CBA performance against traditional RIPAs.
  • Consideration of fixation procedures for antigen conformationality in CBAs.

Main Results:

  • CBAs can detect autoantibodies to clustered AChRs, potentially reducing seronegative MG diagnoses.
  • The diagnostic significance of LRP4 antibodies requires further investigation, especially in Caucasian populations.
  • Live CBAs show promise as RIPA alternatives but need validation; ELISAs are also considered.

Conclusions:

  • CBAs offer a promising avenue for improved MG diagnostics, potentially reducing seronegative cases.
  • Further validation is needed for live CBAs as alternatives to RIPAs.
  • CBAs and ELISAs could serve as screening tools, with RIPAs reserved for quantification.